Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-29

Clinical Trial Update: Phase 2a Study on Allogeneic Osteoblastic Cells Implantation in Lumbar Spinal Fusion [Phase 2]

View source ↗

Summary

Phase 2a study of allogeneic osteoblastic cells implantation for lumbar spinal fusion completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic osteoblastic cells

Snippet

Sponsor: Bone Therapeutics S.A | Conditions: Degenerative Disc Disease | Phase 2 | Status: COMPLETED